Herb use in critical care: What to watch for

Critical Care Nursing Clinics of North America

Volumn 15, Issue 3, 2003, Pages 313-319

  Lu, Yun ^a,b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACF 223; ANGELICA SINENSIS EXTRACT; ANTITHROMBOCYTIC AGENT; ANTIVIRUS AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CLOPIDOGREL; CYCLOSPORIN; DIGOXIN; EPHEDRA EXTRACT; ESMOLOL; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCERYL TRINITRATE; HERBACEOUS AGENT; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; KAVA EXTRACT; LISINOPRIL; METOPROLOL; OPIATE; SALVIA MILTIORRHIZA EXTRACT; STEPHANIA TETRANDRA EXTRACT; UNCLASSIFIED DRUG; VALERIAN; WARFARIN; YOHIMBE EXTRACT;

ADULT; AGITATION; ALZHEIMER DISEASE; ANAMNESIS; ANXIETY DISORDER; ARTICLE; AUTONOMIC NEUROPATHY; BLEEDING; BRONCHOSPASM; CANCER; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL FEATURE; CONFUSION; CORONARY ARTERY DISEASE; CRITICAL ILLNESS; DEPRESSION; DERMATITIS; DIABETES MELLITUS; DRUG ACTIVITY; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ERECTILE DYSFUNCTION; FEVER; HEART INFARCTION; HEMODYNAMIC MONITORING; HERBAL MEDICINE; HUMAN; HYPERREFLEXIA; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOMANIA; INSOMNIA; INTENSIVE CARE; KIDNEY DISEASE; LABORATORY TEST; LIVER TOXICITY; MALE; MENSTRUATION DISORDER; MYOCLONUS; NEPHROTOXICITY; NEUROTOXICITY; PERIPHERAL VASCULAR DISEASE; PHOTOSENSITIVITY DISORDER; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RESTLESSNESS; RIGIDITY; SEXUAL DYSFUNCTION; SIDE EFFECT; STROKE; SUDDEN DEATH; SWEATING; TACHYCARDIA; THROMBOSIS; VERTIGO; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; MEDICINAL PLANT;

ADULT; CRITICAL CARE; DRUG INTERACTIONS; HUMANS; HYPERTENSION; MALE; PLANTS, MEDICINAL; RESPIRATORY INSUFFICIENCY;

EID: 0142212419     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-5885(02)00102-8     Document Type: Review

References (53)

1. Guo T. Introduction to traditional Chinese medicine. 3rd edition. Bei Jin: Public Health Publishing House of People's Republic of China; 2001.
2. Zhong Hua Ben Cao. Chinese Materia Medica. 3rd edition. Bei Jin: Publishing House of People's Republic of China; 2001.
3. Kuhn MA. Herbal remedies: drug-herb interactions. Crit Care Nurse 2002;22:22-6.
4. Einsenberg DM. Complementary, alternative and integrative medical therapies: epidemiology and overview. clinical update and implications for practice. Complementary and Integrative Medicine 2001;Feb:11-4.
5. Einsenberg DM, Davis RB, Ettner SL, Appel S,Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990- 1997: results of a followup national survey. JAMA 1998;279: 1548-53.
6. Anonymous. Global strategy launched to integrate traditional and alternative medicine. Pharmaceutical Journal 2002;268:674.
7. Kayne S. A need for controls. Good Clinical Practice Journal 2001;8(5):9-11.
8. Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Klein S, et al. The complete German commission monographs: therapeutic guide to herbal medicines. Austin, Texas: American Botanical Council; 1998.
9. Lacomblez L, Bensimon G, Isnard F, Diquet B, LeCrubier Y, Puech AJ. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. Clin Pharmacol Ther 1989;45:241-51.
10. Guay AT, Spark RF, Jacobson J, Murray FT, Geisser ME. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial. Int J Impot Res 2002;14: 25-31.
11. Landis E, Shore E. Yohimbine-induced bronchospasm. Chest 1989;96:1424.
12. Langer SZ. Presynaptic regulation of the release of catecholamines. Pharmacol Rev 1980;32:337-62.
13. Bédard M. Ma huang: is it a safe product? Can Pharm J 2000;133(9):38-9.
14. Pentel P. Toxicity of over-the-counter stimulants. JAMA 1984;252:1898-903.
15. Liu YM, Sheu SJ, Chiou SH, Chang HC, Chen YP. A comparative study on commercial samples of ephedrae herba. Planta Med 1993;59:376-8.
16. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8.
17. FDA. Letter to health care professionals on FDA concerned about botanical products, including dietary supplements, containing aristolochic acid. May 31, 2000. Available at: http://www.fda.gov/medwatch/safety/2000/safety00.htm. Date accessed: Feb 11, 2003.
18. Ernst E, Pittler MH. Risks associated with herbal medicinal products. Wien Med Wochenschr 2002;152:183-9.
19. Muniz Martinez M-C, Nortier J, Vereerstraeten P, Vanherweghem J-L. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 2002;17:408-12.
20. Ho NK, Loh KC. Gynaecomastia and the herbal tonic ''Dong Quai''. Singapore Med J 2001;42:286-7.
21. Jones SC, Miederhoff P, Karnes HT. The development of a human tissue model to determine the effect of plantderived dietary supplements on prothrombin time. Journal of Herbal Pharmacotherapy 2001;1:21-34.
22. Taylor M. Nonhormonal alternatives for the menopause syndrome. Infertil Reprod Med Clin North Am 2001;12:669-85.
23. Goh SY, Loh KC. Gynaecomastia and the herbal tonic "Dong Quai". Singapore Med J 2001;42:115-6.
24. Lerner JH. TCM/Kampo therapy also efficacious for menopause. Altern Ther Health Med 2001;7:21.
25. Stenton SB, Bungard TJ, Ackman ML. Interactions between warfarin and herbal products, minerals, and vitamins: a pharmacist's guide. Can J Hosp Pharm 2001;54: 184-90.
26. Lawrence JM, Reckless JPD. Garlic in cardiovascular disease - the last word? Br J Cardiol 2002;19:255-7.
27. Lin MC,Wang EJ, Lee C, Chin KT, Liu D, Chiu JF, et al. Garlic inhibits microsomal triglyceride transfer protein gene expression in human liver and intestinal cell lines and in rat intestine. J Nutr 2002;132: 1165-8.
28. Bedard M. Ginkgo biloba. Can Pharm J 2001;134(1):25-6.
29. Li XF, Ma M, Scherban K, Tam YK. Liquid chromatography-electrospray mass spectrometric studies of ginkgolides and bilobalide using simultaneous monitoring of proton, ammonium and sodium adducts. Analyst 2002;127:641-6.
30. Kaufmann H. Treatment of patients with orthostatic hypotension and syncope. Clin Neuropharmacol 2002;25:133-41.
31. Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients: a randomised, double blind, placebo-crossover trial. Thromb Haemost 2002;87:1075-6.
32. Xiao P-G, Xing S-T, Wang L-W. Immunological aspects of Chinese medicinal plants as antiaging drugs. J Ethnopharmacol 1993;38:167-75.
33. Avakian EV, Sugimoto RB, Taguchi S, Horvath SM. Effect of Panax ginseng extract on energy metabolism during exercise in rats. Planta Med 1984;50:151-4.
34. Chung BS. Studies on the components of Korean ginseng II on the composition of ginseng essential oils. Korean J Pharmacog 1976;7:41-4.
35. Liberti LE, Der Marderosian A. Evaluation of commercial ginseng products. J Pharm Sci 1978;67:1487-9.
36. Vuksan V, Sievenpiper JL, Koo VYY, Francis T, Beljan-Zdravkovic U, Xu Z, et al. American ginseng (Panax quinquefolius) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000;160:1009-13.
37. Anonymous. Ginseng: the root of the problem. Emerg Med 1980a;12:124-6.
38. Bedard M. Kava: the root to happiness? Can Pharm J 2000;133:26-7.
39. Stevinson C, Huntley A, Ernst E. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Saf 2002;25:251-61.
40. Anonymous. Be cautious with kava preparations. Med Today 2002;3(5):7.
41. Agostinis P, Vantieghem A, Merlevede W, de Witte PA. Hypericin in cancer treatment: more light on the way. Intern J Biochem Cell Biol 2002;34:221-41.
42. Houghton PJ. The biological activity of valerian and related plants. J Ethnopharmacol 1988;22:121-42.
43. Willey LB, Mady SP, Cobaugh DJ, Wax PM. Valerian overdose: a case report. Vet Hum Toxicol 1995;37:364-5.
44. Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with valerian root withdrawal. JAMA 1998;280:1566-77.
45. Jorm AF, Christensen H, Griffiths KM, Rodgers B. Effectiveness of complementary and self-help treatments for depression. Med J Aust 2002;176(Suppl):S84-96.
46. Allard J, Giuliano F. Central nervous system agents in the treatment of erectile dysfunction: how do they work? Curr Urol Rep 2001;2:488-94.
47. Frohman EM. Sexual dysfunction in neurologic disease. Clin Neuropharmacol 2002;25:126-32.
48. Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of hypericum extract. J Geriat Psych Neurol 1994;7:57-9.
49. Beer AM, Ostermann T. Cyclosporine interaction with St. John's wort (Hypericum perforatum) increases the risk of graft rejection and causes a raise of the daily medication costs. Med Klin 2001;96:480-4.
50. Anonymous. Antiretroviral-herbal interactions. Pharmaceutical Journal 2002;268:696.
51. Scott GN, Elmer GW. Update on natural product-drug interactions. Am J Health Syst Pharm 2002;59:339-47.
52. Biber A, Fischer H, Romer A, Chatterjee SS. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Pharmacopsychiatry 1998;31(Suppl):36-43.
53. Lee K-H, Wang H-K, Itokawa H, Morris-Natschke SL. Current perspectives on Chinese medicines and dietary supplements in China, Japan and the United States. Journal of Food & Drug Analysis 2000;8: 219-28.